SCHEMBL32688147

SCHEMBL32688147

N#Cc1c(SCc2nnn[nH]2)[nH]c(=O)c(C#N)c1-c1ccccc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 13/20 0.40
▸ HSD11B2 P80365 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ TNF P01375 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ NOD2 Q9HC29 1/20 0.38
▸ NOD1 Q9Y239 1/20 0.38
▸ ADORA1 P30542 1/20 0.36
▸ KDM4E B2RXH2 2/20 0.34
▸ GLA P06280 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ BRD4 O60885 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688289 0.90 ADORA1 (0.40) HSD11B1HSD11B2ALDH1A1MEN1KMT2A
SCHEMBL32688028 0.90 HSD11B1 (0.47) HSD11B1HSD11B2ALDH1A1MEN1KMT2A
SCHEMBL32688250 0.89 HSD11B1 (0.41) HSD11B1HSD11B2MEN1KMT2APOLB
SCHEMBL32688405 0.87 MEN1 (0.41) HSD11B1HSD11B2ALDH1A1MEN1KMT2A
SCHEMBL32688115 0.86 HPGD (0.41) HSD11B1HSD11B2ALDH1A1MEN1KMT2A
SCHEMBL32688050 0.83 HSD11B1 (0.44) HSD11B1HSD11B2POLBKDM4EGLA
SCHEMBL32688008 0.82 MEN1 (0.42) HSD11B1HSD11B2ALDH1A1MEN1KMT2A
SCHEMBL32688285 0.79 POLB (0.40) HSD11B1MEN1KMT2ATDP1TNF
SCHEMBL32688201 0.78 HSD11B1 (0.36) HSD11B1HSD11B2
SCHEMBL32688166 0.78 HSD11B1 (0.41) HSD11B1HSD11B2MEN1KMT2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK HSD11B1 61/4885HSD11B2 131/4885ALDH1A1 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback